GRNA Market Size, Trend, Growth, Industry Analysis 2034
GRNA Market By Product Type (Synthetic gRNA, Plasmid-Encoded gRNA Constructs, RNP Complexes (gRNA + Cas), In-vitro Transcribed (IVT) gRNA, and Multiplex gRNA Libraries), By Application (Genome Editing, Diagnostics, Cell & Gene Therapy, Functional Genomics Screens, and Agricultural Biotechnology), By End-User (Academic & Research Institutes, Agro-industrial Firms, Contract Research Organizations (CROs), Biotechnology & Pharmaceutical Companies, and Hospitals & Diagnostic Laboratories), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2026 - 2034
Category: Biotechnology Report Format : PDF
Pages: 229 Report Code: ZMR-10695
Published Date: Jul-2026 Status : Published
| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 718 Billion | USD 3,308 Million | 18.5% | 2025 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global GRNA Market, (2026 - 2034) (USD Billion)
- 2.2 Global GRNA Market : snapshot
- Chapter 3. Global GRNA Market - Industry Analysis
- 3.1 GRNA Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The rising adoption of CRISPR-based gene editing technologies drive the GRNA market
- 3.3 Market Restraints
- 3.3.1. High development and manufacturing costs hamper the growth of the GRNA industry
- 3.4 Market Opportunities
- 3.4.1. Increasing technological innovation offer a lucrative opportunity for the GRNA market
- 3.5 Market Challenges
- 3.5.1. The limited clinical validation for several applications pose a significant challenge to the growth of the GRNA industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End User
- Chapter 4. Global GRNA Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global GRNA Market: company market share, 2025
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global GRNA Market - Product Type Analysis
- 5.1 Global GRNA Market overview: By Product Type
- 5.1.1 Global GRNA Market share, By Product Type, 2025 and 2034
- 5.2 Synthetic gRNA
- 5.2.1 Global GRNA Market by Synthetic gRNA, 2026 - 2034 (USD Billion)
- 5.3 Plasmid-Encoded gRNA Constructs
- 5.3.1 Global GRNA Market by Plasmid-Encoded gRNA Constructs, 2026 - 2034 (USD Billion)
- 5.4 RNP Complexes (gRNA + Cas)
- 5.4.1 Global GRNA Market by RNP Complexes (gRNA + Cas), 2026 - 2034 (USD Billion)
- 5.5 In-vitro Transcribed (IVT) gRNA
- 5.5.1 Global GRNA Market by In-vitro Transcribed (IVT) gRNA, 2026 - 2034 (USD Billion)
- 5.6 Multiplex gRNA Libraries
- 5.6.1 Global GRNA Market by Multiplex gRNA Libraries, 2026 - 2034 (USD Billion)
- 5.1 Global GRNA Market overview: By Product Type
- Chapter 6. Global GRNA Market - Application Analysis
- 6.1 Global GRNA Market overview: By Application
- 6.1.1 Global GRNA Market share, By Application, 2025 and 2034
- 6.2 Genome Editing
- 6.2.1 Global GRNA Market by Genome Editing, 2026 - 2034 (USD Billion)
- 6.3 Diagnostics
- 6.3.1 Global GRNA Market by Diagnostics, 2026 - 2034 (USD Billion)
- 6.4 Cell & Gene Therapy
- 6.4.1 Global GRNA Market by Cell & Gene Therapy, 2026 - 2034 (USD Billion)
- 6.5 Functional Genomics Screens
- 6.5.1 Global GRNA Market by Functional Genomics Screens, 2026 - 2034 (USD Billion)
- 6.6 Agricultural Biotechnology
- 6.6.1 Global GRNA Market by Agricultural Biotechnology, 2026 - 2034 (USD Billion)
- 6.1 Global GRNA Market overview: By Application
- Chapter 7. Global GRNA Market - End User Analysis
- 7.1 Global GRNA Market overview: By End User
- 7.1.1 Global GRNA Market share, By End User, 2025 and 2034
- 7.2 Academic & Research Institutes
- 7.2.1 Global GRNA Market by Academic & Research Institutes, 2026 - 2034 (USD Billion)
- 7.3 Agro-industrial Firms
- 7.3.1 Global GRNA Market by Agro-industrial Firms, 2026 - 2034 (USD Billion)
- 7.4 Contract Research Organizations (CROs)
- 7.4.1 Global GRNA Market by Contract Research Organizations (CROs), 2026 - 2034 (USD Billion)
- 7.5 Biotechnology & Pharmaceutical Companies
- 7.5.1 Global GRNA Market by Biotechnology & Pharmaceutical Companies, 2026 - 2034 (USD Billion)
- 7.6 Hospitals & Diagnostic Laboratories
- 7.6.1 Global GRNA Market by Hospitals & Diagnostic Laboratories, 2026 - 2034 (USD Billion)
- 7.1 Global GRNA Market overview: By End User
- Chapter 8. GRNA Market - Regional Analysis
- 8.1 Global GRNA Market Regional Overview
- 8.2 Global GRNA Market Share, by Region, 2025 & 2034 (USD Billion)
- 8.3. North America
- 8.3.1 North America GRNA Market, 2026 - 2034 (USD Billion)
- 8.3.1.1 North America GRNA Market, by Country, 2026 - 2034 (USD Billion)
- 8.3.1 North America GRNA Market, 2026 - 2034 (USD Billion)
- 8.4 North America GRNA Market, by Product Type, 2026 - 2034
- 8.4.1 North America GRNA Market, by Product Type, 2026 - 2034 (USD Billion)
- 8.5 North America GRNA Market, by Application, 2026 - 2034
- 8.5.1 North America GRNA Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 North America GRNA Market, by End User, 2026 - 2034
- 8.6.1 North America GRNA Market, by End User, 2026 - 2034 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe GRNA Market, 2026 - 2034 (USD Billion)
- 8.4.2.1 Europe GRNA Market, by Country, 2026 - 2034 (USD Billion)
- 8.4.2 Europe GRNA Market, 2026 - 2034 (USD Billion)
- 8.4 Europe GRNA Market, by Product Type, 2026 - 2034
- 8.4.1 Europe GRNA Market, by Product Type, 2026 - 2034 (USD Billion)
- 8.5 Europe GRNA Market, by Application, 2026 - 2034
- 8.5.1 Europe GRNA Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Europe GRNA Market, by End User, 2026 - 2034
- 8.6.1 Europe GRNA Market, by End User, 2026 - 2034 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific GRNA Market, 2026 - 2034 (USD Billion)
- 8.5.3.1 Asia Pacific GRNA Market, by Country, 2026 - 2034 (USD Billion)
- 8.5.3 Asia Pacific GRNA Market, 2026 - 2034 (USD Billion)
- 8.4 Asia Pacific GRNA Market, by Product Type, 2026 - 2034
- 8.4.1 Asia Pacific GRNA Market, by Product Type, 2026 - 2034 (USD Billion)
- 8.5 Asia Pacific GRNA Market, by Application, 2026 - 2034
- 8.5.1 Asia Pacific GRNA Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Asia Pacific GRNA Market, by End User, 2026 - 2034
- 8.6.1 Asia Pacific GRNA Market, by End User, 2026 - 2034 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America GRNA Market, 2026 - 2034 (USD Billion)
- 8.6.4.1 Latin America GRNA Market, by Country, 2026 - 2034 (USD Billion)
- 8.6.4 Latin America GRNA Market, 2026 - 2034 (USD Billion)
- 8.4 Latin America GRNA Market, by Product Type, 2026 - 2034
- 8.4.1 Latin America GRNA Market, by Product Type, 2026 - 2034 (USD Billion)
- 8.5 Latin America GRNA Market, by Application, 2026 - 2034
- 8.5.1 Latin America GRNA Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Latin America GRNA Market, by End User, 2026 - 2034
- 8.6.1 Latin America GRNA Market, by End User, 2026 - 2034 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa GRNA Market, 2026 - 2034 (USD Billion)
- 8.7.5.1 The Middle-East and Africa GRNA Market, by Country, 2026 - 2034 (USD Billion)
- 8.7.5 The Middle-East and Africa GRNA Market, 2026 - 2034 (USD Billion)
- 8.4 The Middle-East and Africa GRNA Market, by Product Type, 2026 - 2034
- 8.4.1 The Middle-East and Africa GRNA Market, by Product Type, 2026 - 2034 (USD Billion)
- 8.5 The Middle-East and Africa GRNA Market, by Application, 2026 - 2034
- 8.5.1 The Middle-East and Africa GRNA Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 The Middle-East and Africa GRNA Market, by End User, 2026 - 2034
- 8.6.1 The Middle-East and Africa GRNA Market, by End User, 2026 - 2034 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Thermo Fisher Scientific
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Synthego Corporation
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Integrated DNA Technologies (Danaher)
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Merck KGaA - Sigma-Aldrich
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Agilent Technologies
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Twist Bioscience
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Intellia Therapeutics
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Eurofins Genomics
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 GenScript Biotech
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Horizon Discovery (Revvity)
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 CRISPR Therapeutics
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Editas Medicine
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Applied Biological Materials (abm)
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Beam Therapeutics
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 OriGene Technologies
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Lonza Group
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Dharmacon (Horizon)
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Takara Bio Inc.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Bioneer Corporation
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Sangamo Therapeutics
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 and others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Thermo Fisher Scientific
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global GRNA Market, 2026 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global GRNA Market attractiveness, By Product Type
- 6. Global GRNA Market attractiveness, By Application
- 7. Global GRNA Market attractiveness, By End User
- 8. Global GRNA Market share by Product Type, 2026 and 2034 (USD Billion)
- 9. Global GRNA Market by Synthetic gRNA, 2026 - 2034 (USD Billion)
- 10. Global GRNA Market by Plasmid-Encoded gRNA Constructs, 2026 - 2034 (USD Billion)
- 11. Global GRNA Market by RNP Complexes (gRNA + Cas), 2026 - 2034 (USD Billion)
- 12. Global GRNA Market by In-vitro Transcribed (IVT) gRNA, 2026 - 2034 (USD Billion)
- 13. Global GRNA Market by Multiplex gRNA Libraries, 2026 - 2034 (USD Billion)
- 14. Global GRNA Market share by Application, 2026 and 2034 (USD Billion)
- 15. Global GRNA Market by Genome Editing, 2026 - 2034 (USD Billion)
- 16. Global GRNA Market by Diagnostics, 2026 - 2034 (USD Billion)
- 17. Global GRNA Market by Cell & Gene Therapy, 2026 - 2034 (USD Billion)
- 18. Global GRNA Market by Functional Genomics Screens, 2026 - 2034 (USD Billion)
- 19. Global GRNA Market by Agricultural Biotechnology, 2026 - 2034 (USD Billion)
- 20. Global GRNA Market share by End User, 2026 and 2034 (USD Billion)
- 21. Global GRNA Market by Academic & Research Institutes, 2026 - 2034 (USD Billion)
- 22. Global GRNA Market by Agro-industrial Firms, 2026 - 2034 (USD Billion)
- 23. Global GRNA Market by Contract Research Organizations (CROs), 2026 - 2034 (USD Billion)
- 24. Global GRNA Market by Biotechnology & Pharmaceutical Companies, 2026 - 2034 (USD Billion)
- 25. Global GRNA Market by Hospitals & Diagnostic Laboratories, 2026 - 2034 (USD Billion)
- 26. Global GRNA Market share, by Region, 2026 and 2034
- 27. North America GRNA Market, 2026 - 2034 (USD Billion)
- 28. Europe GRNA Market, 2026 - 2034 (USD Billion)
- 29. Asia Pacific GRNA Market, 2026 - 2034 (USD Billion)
- 30. Latin America GRNA Market, 2026 - 2034 (USD Billion)
- 31. The Middle-East and Africa GRNA Market, 2026 - 2034 (USD Billion)
Table Of Tables
- 1. Global GRNA Market: Snapshot
- 2. Drivers of the GRNA Market: impact analysis
- 3. North America GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 4. North America GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 5. North America GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 6. U.S. GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 7. U.S. GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 8. U.S. GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 9. Canada GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 10. Canada GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 11. Canada GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 12. Europe GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 13. Europe GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 14. Europe GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 15. Germany GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 16. Germany GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 17. Germany GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 18. France GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 19. France GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 20. France GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 21. U.K. GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 22. U.K. GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 23. U.K. GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 24. Italy GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 25. Italy GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 26. Italy GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 27. Spain GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 28. Spain GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 29. Spain GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 30. Rest of Europe GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 31. Rest of Europe GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 32. Rest of Europe GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 33. Asia Pacific GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 34. Asia Pacific GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 35. Asia Pacific GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 36. China GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 37. China GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 38. China GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 39. Japan GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 40. Japan GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 41. Japan GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 42. India GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 43. India GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 44. India GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 45. South Korea GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 46. South Korea GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 47. South Korea GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 48. South-East Asia GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 49. South-East Asia GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 50. South-East Asia GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 51. Rest of Asia Pacific GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 52. Rest of Asia Pacific GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 53. Rest of Asia Pacific GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 54. Latin America GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 55. Latin America GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 56. Latin America GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 57. Brazil GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 58. Brazil GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 59. Brazil GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 60. Mexico GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 61. Mexico GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 62. Mexico GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 63. Rest of Latin America GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 64. Rest of Latin America GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 65. Rest of Latin America GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 66. The Middle-East and Africa GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 67. The Middle-East and Africa GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 68. The Middle-East and Africa GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 69. GCC Countries GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 70. GCC Countries GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 71. GCC Countries GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 72. South Africa GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 73. South Africa GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 74. South Africa GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
- 75. Rest of Middle-East Africa GRNA Market revenue, By Product Type, 2026 - 2034 (USD Billion)
- 76. Rest of Middle-East Africa GRNA Market revenue, By Application, 2026 - 2034 (USD Billion)
- 77. Rest of Middle-East Africa GRNA Market revenue, By End User, 2026 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
gRNA (guide RNA) is a synthetic RNA molecule used in CRISPR gene-editing technology to direct the CRISPR-associated protein (Cas), mostly Cas9, to the desired location in the genome.
The gRNA (guide RNA) market is primarily driven by the rapid adoption of CRISPR-based gene-editing technologies across biomedical research, drug discovery, and gene therapy development. Increasing investments in cell and gene therapies, expanding genomics and functional genomics research, and growing demand for precision medicine are accelerating the use of synthetic and custom-designed gRNAs.
The gRNA (guide RNA) market faces several challenges, including high development and manufacturing costs, stringent regulatory requirements for gene-editing therapies, and limited clinical validation for many CRISPR-based applications. Concerns regarding off-target gene editing, delivery efficiency, and long-term safety continue to slow clinical adoption and regulatory approvals.
Based on the application, the genome editing segment is expected to dominate the GRNA market growth during the projected period.
The gRNA (guide RNA) market is being transformed by innovations in AI-powered gRNA design, which improve target selection and minimize off-target effects, enhancing the efficiency of CRISPR-based genome editing. The development of chemically modified synthetic gRNAs with greater stability and nuclease resistance is expanding their use in both research and clinical applications. Advances in base editing, prime editing, multiplex genome editing, and CRISPR-Cas12/Cas13 platforms are broadening the scope of genome engineering beyond conventional CRISPR-Cas9 systems.
According to the report, the global GRNA market size was worth around USD 718 million in 2025 and is predicted to grow to around USD 3,308 million by 2034.
The global GRNA market is expected to grow at a CAGR of 18.5% during the forecast period.
The global GRNA industry growth is expected to be led by North America over the forecast period.
The global GRNA market is dominated by players like Thermo Fisher Scientific, Synthego Corporation, Integrated DNA Technologies (Danaher), Merck KGaA - Sigma-Aldrich, Agilent Technologies, Twist Bioscience, Intellia Therapeutics, Eurofins Genomics, GenScript Biotech, Horizon Discovery (Revvity), CRISPR Therapeutics, Editas Medicine, Applied Biological Materials (abm), Beam Therapeutics, OriGene Technologies, Lonza Group, Dharmacon (Horizon), Takara Bio Inc., Bioneer Corporation, and Sangamo Therapeutics, among others.
The GRNA market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
HappyClients
